It started with a belief

Octapharma was founded 40 years ago to provide haemophilia patients with a safer, higher-quality factor VIII (FVIII) concentrate.

News & Stories

Check out our latest stories

Raising awareness of immune thrombocytopenic purpura

Heroes in the Fight: Octapharma To Be Honored for Myositis Research at TMA Annual Patient Conference

Innovation and science

Driven by curiosity

Annual Report 2022

Octapharma's prothrombin complex concentrate, Balfaxar®, receives FDA approval for warfarin reversal in urgent surgery & invasive procedures

Octapharma lectures

ISTH 2023

Under the Spotlight Symposium

ISTH 2023

Under the Spotlight Symposium

EHA 2023 Congress

Octapharma Update-In-Hematology

Check all our events

Patient Engagement

Octapharma takes an active role in our community

We sponsor and support organisations worldwide.

Learn how we engage with patients

Careers and Jobs

Explore a new world of opportunities

Our people source, distribute and invent medicines that transform patients' lives. Join our family and make a difference.

Working with Octapharma